A handful of start-up firms are testing therapies that target specific epigenetic markers to treat everything from high ...
This offseason, the Philadelphia Phillies bullpen changed for the second consecutive offseason. In free agency, the team signed Brad Keller to a two-year, $22 million contract. Coming off a dominant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results